{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:37:23Z","timestamp":1772127443476,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01HL10715301"],"award-info":[{"award-number":["P01HL10715301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.biomaterials.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T07:42:37Z","timestamp":1433576557000},"page":"125-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor"],"prefix":"10.1016","volume":"64","author":[{"given":"S.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bedja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Amuzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"Yarema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2015.06.001_bib1","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1073\/pnas.73.12.4339","article-title":"Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia","volume":"73","author":"Chatterjee","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-2275(20)36996-0","article-title":"Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias","volume":"17","author":"Dawson","year":"1976","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib3","series-title":"The Johns Hopkins Textbook of Dyslipidemia","year":"2012"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib4","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.113.007559","article-title":"Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E\u2212\/\u2212 mice and rabbits fed a high-fat and -cholesterol diet","volume":"129","author":"Chatterjee","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jbm.820170110","article-title":"Biomaterials for drug delivery systems","volume":"17","author":"Buckles","year":"1983","journal-title":"J.\u00a0Biomed. Mater. Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib6","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/aic.690491202","article-title":"Advances in biomaterials, drug delivery, and bionanotechnology","volume":"49","author":"Langer","year":"2004","journal-title":"AIChE J."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425241003602259","article-title":"Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/bit.21885","article-title":"Polymeric particles conjugated with a ligand to VCAM-1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis","volume":"101","author":"Deosarkar","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2014.08.006","article-title":"Drug and cell delivery for cardiac regeneration","author":"Hastings","year":"2015","journal-title":"Adv. Drug Deliv. Rev. 84"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib10","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1016\/S0142-9612(02)00182-5","article-title":"New polymeric carriers for controlled drug delivery following inhalation or injection","volume":"23","author":"Fu","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0142-9612(02)00242-9","article-title":"Crystalline and dynamic mechanical behaviors of synthesized poly(sebacic anhydride-co-ethylene glycol)","volume":"24","author":"Chan","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jconrel.2004.02.018","article-title":"Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs","volume":"96","author":"Fiegel","year":"2004","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-2275(20)30162-0","article-title":"Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice","volume":"43","author":"Garner","year":"2002","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10719-010-9292-3","article-title":"Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs","volume":"27","author":"Aich","year":"2010","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib15","first-page":"S963","article-title":"AT2 signaling is a Positive prognostic and therapeutic modifier of Marfan syndrome: lessons on the inequality of ACEi and ARBs","volume":"120","author":"Habashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib16","first-page":"6602","article-title":"Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1","volume":"63","author":"Olson","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"H\u00f6rkk\u00f6","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/mabi.200600256","article-title":"Synthesis and erosion properties of PEG-containing polyanhydrides","volume":"7","author":"Hou","year":"2007","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib19","first-page":"183","article-title":"Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances","volume":"26","author":"Radin","year":"1993","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.ATV.19.3.525","article-title":"ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages","volume":"19","author":"Boisvert","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib21","doi-asserted-by":"crossref","first-page":"15747","DOI":"10.1074\/jbc.270.26.15747","article-title":"Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase","volume":"270","author":"Takahashi","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1073\/pnas.80.5.1313","article-title":"Localization of urinary lactosylceramide in cytoplasmic vesicles of renal tubular cells in homozygous familial hypercholesterolemia","volume":"80","author":"Chatterjee","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0006-291X(91)91225-2","article-title":"Lactosylceramide stimulates aortic smooth muscle cell proliferation","volume":"181","author":"Chatterjee","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.ATV.18.5.794","article-title":"Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages","volume":"18","author":"Yoshida","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib25","doi-asserted-by":"crossref","first-page":"34349","DOI":"10.1074\/jbc.273.51.34349","article-title":"Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells","volume":"273","author":"Bhunia","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.RES.82.5.540","article-title":"Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in\u00a0vitro","volume":"82","author":"Arai","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib27","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.ATV.18.10.1523","article-title":"Sphingolipids in atherosclerosis and vascular biology","volume":"18","author":"Chatterjee","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib28","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1073\/pnas.0308684101","article-title":"Lactosylceramide recruits PKCa\/e and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells","volume":"101","author":"Gong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/01.RES.0000185327.45463.A8","article-title":"Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells","volume":"97","author":"Rajesh","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib30","doi-asserted-by":"crossref","first-page":"24515","DOI":"10.1074\/jbc.M413862200","article-title":"Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1\/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator","volume":"280","author":"Glaros","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2015.06.001_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/glycob\/cwu020","article-title":"Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1\/2 in cardiomyocytes","volume":"24","author":"Mishra","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biomaterials.2009.09.033","article-title":"Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in\u00a0vivo","volume":"31","author":"Tang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib33","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1089\/ten.tea.2008.0326","article-title":"Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds","volume":"15","author":"Kim","year":"2009","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.biomaterials.2015.06.001_bib34","doi-asserted-by":"crossref","first-page":"e63726","DOI":"10.1371\/journal.pone.0063726","article-title":"Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model","volume":"8","author":"Chatterjee","year":"2013","journal-title":"PLoS One"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215005098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215005098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:09:44Z","timestamp":1758902984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961215005098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"alternative-id":["S0142961215005098"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.06.001","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}